Funding for this research was provided by:
Program of Experimental Medicine Graduate Scholarship
Translational and Personalized Medicine Initiative (TPMI)/NL SUPPORT Educational Funding
O’Dea Research Fellowship
Research and Development Corporation (5404.1699.104)
Canada Research Chairs (230457)
Canada Foundation for Innovation (33621)
Health Care Foundation Project Fund
Received: 24 October 2019
Accepted: 10 January 2020
First Online: 22 January 2020
Ethics approval and consent to participate
: The study was approved by the Newfoundland and Labrador Health Research Ethics Board (reference number: 2018.088) on 11/07/2018 prior to the enrollment of first participant (retrospectively registered at ExternalRef removed: NCT04066972, 26/08/2019). During recruitment, participants were given at least one week to review the study protocol and the consent form. All participants signed and provided written informed consent to the principal investigator prior to entering the study.
: Not Applicable.
: The authors declare no competing interests.